Clinical Research Committee awards

Explore our recently funded awardees and learn more about how we make funding decisions.

Learn more about the committee

Clinical Research Funding Scheme

May 2026

PLATO imaging sample collection

Vicky Goh.

Professor Vicky Goh

King's College London

Andrew Scarsbrook.

Professor Andrew Scarsbrook

University of Leeds

UK-MRA Myeloma XVIII iFIT: Immunotherapy approaches adapted for fitness in newly diagnosed transplant ineligible patients with myeloma

Gordon Cook.

Professor Gordon Cook

University of Leeds

Charlotte Pawlyn.

Dr Charlotte Pawlyn

Institute of Cancer Research

STRatIfication of vulvar squamous cell carcinoma by HPV and p53 status to guide excision

Sudha Sundar.

Professor Sudha Sundar

University of Birmingham

Rachel Pounds.

Dr Rachel Pounds

University of Birmingham

TRANSLATE-TADPOLE: understanding the impact of axillary surgery on the immune response and disease recurrence in early breast cancer

Stuart McIntosh.

Dr Stuart McIntosh

Queen's University Belfast

Kienan Savage.

Dr Kienan Savage

Queen's University Belfast

HARRIS: tHorAcic Re-iRadIation Study

Stephen Harrow.

Dr Stephen Harrow

NHS Lothian

Robert Rulach.

Dr Robert Rulach

Oxford University Hospitals NHS Foundation Trust

High dose palliative radiotherapy for inoperable gastric cancer: A randomised phase 2 trial of radiotherapy in locally advanced adenocarcinoma of the stomach or type 3 gastro-oesophageal junction, with or without systemic anti-cancer therapy

Sarah Gwynne.

Dr Sarah Gwynne

Swansea Bay University Health Board

Amy Case.

Dr Amy Case

Swansea Bay University Health Board

Christopher Jones.

Dr Christopher Jones

University of Cambridge

PREFECT: a Phase I trial of 5-fluorouracil (5-FU) chemoradiation, followed by 5-FU and all-trans retinoic acid continuation chemotherapy for children, teenagers and young adults with primary or relapsed localised high-risk posterior fossa ependymoma

John-Paul Kilday.

Professor John-Paul Kilday

Manchester University NHS Foundation Trust

Timothy Ritzmann.

Dr Timothy Ritzmann

University of Nottingham

Investigating precision medicine in the adjuvant setting: A phase III clinical trial in biliary tract cancer

Professor John Bridgewater

University College London

POLCA-DOT Trial "POLyp CAncers Decisions Of Treatment"

Doug Speake.

Mr Doug Speake

University of Edinburgh

Farhat Din.

Professor Farhat Din

University of Edinburgh

Image of Kevin Myant.

Dr Kevin Myant

University of Edinburgh

November 2025

CRISTAL-APC: a multi-centre, open label Phase 1/randomised Phase 2 study of VP-002, a C-C motif chemokine receptor 1 inhibitor, given orally in combination with nab-paclitaxel and gemcitabine to patients with advanced pancreatic ductal adenocarcinoma

Dr Bristi Basu

University of Cambridge

Dr Fieke Froeling

University of Glasgow

TRILBY: tracking recurrence with individualised liquid biopsy (formerly immunoREACH/TRACE H&N)

Dr Ben O'Leary

The Institute of Cancer Research

Professor Emma Hall

The Institute of Cancer Research

B5forMDS: a single arm, Phase 2, multi-centre, bayesian, intra-patient dose de-escalation trial to assess the activity of VitB5 for the treatment of patients with SF3B1 mutant MDS

Dr Onima Chowdhury

University of Oxford

Dr Kevin Rouault-Pierre

Barts Cancer Institute, Queen Mary University of London

TRAFIK-CAR: next-generation autologous chimeric antigen receptor T cells for hepatocellular carcinoma

Head and shoulders icon navy.

Dr Claire Roddie

University College London

VALTIVE-C: validation of Tie2 for VEGFi in metastatic colorectal cancer

Dr Michael Braun

The Christie NHS Foundation Trust

Professor Gordon Jayson

The Christie NHS Foundation Trust

The University of Manchester

Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial programme; RAINBO Translational Research Biobank

Professor Emma Davidson

The University of Manchester

Dr Melanie Powell

Barts Health NHS Trust

rEECur: international randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory ewing sarcoma

Professor Martin McCabe

The University of Manchester

Mr Piers Gaunt

University of Birmingham

Real-world ambispective observational study of molecular responses and clinical outcomes in patients with myeloproliferative neoplasms

Dr Jennifer O'Sullivan

Guy’s and St. Thomas’ NHS Foundation Trust

Dr Alesia Khan

Leeds Teaching Hospitals NHS Trust

A safety and feasibility study investigating the use of non-invasive focused ultrasound with intravenous administration of carboplatin in children, teenagers and young adults diagnosed with progressive/recurrent high-risk brain tumours

Dr Elwira Szychot

Great Ormond Street Hospital for Children NHS Foundation Trust

Professor Antonios Pouliopoulos

King's College London

Professor Darren Hargrave

UCL Great Ormond Street Institute of Child Health

Explore the Clinical Research Funding Scheme